Olivier Jarry MBA

Olivier Jarry has managed innovation at the crossroads of technology, healthcare, and patient-centricity for three decades on five continents. He has had several executive roles in life sciences multinationals such as leading the global Diabetes Care division of Bayer. He has also had more entrepreneur roles including CEO of a nanobiotechnology company in neurology, LIFNano Therapeutics, creating a new for-profit healthcare system in India on behalf of Novartis, “Arogya Parivar”, including diabetes. He is on the Board of several companies related to diabetes such as Rimini, Fit4D and Skipta.